[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-who-owns-jazz-pharmaceuticals-top-shareholders-and-recent-insider-trades-ES":222},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[150,154,158,162,166,170,174,178,182,186,190,194,198,202,206,210,214,218],{"slug":151,"title":152,"modified":153},"bloomberg","Bloomberg","2025-01-16T14:23:44",{"slug":155,"title":156,"modified":157},"morningstar","Morningstar","2025-01-16T14:25:16",{"slug":159,"title":160,"modified":161},"sentieo","Sentieo","2025-01-16T17:58:27",{"slug":163,"title":164,"modified":165},"googlefinance","Google Finance","2025-01-17T19:39:37",{"slug":167,"title":168,"modified":169},"tradingview","TradingView","2025-01-16T18:17:01",{"slug":171,"title":172,"modified":173},"factset","Factset","2025-01-16T18:20:16",{"slug":175,"title":176,"modified":177},"finviz","Finviz","2025-01-16T18:23:40",{"slug":179,"title":180,"modified":181},"ycharts","YCharts","2025-01-16T18:32:19",{"slug":183,"title":184,"modified":185},"marketbeat","MarketBeat","2025-03-11T00:27:23",{"slug":187,"title":188,"modified":189},"benzinga","Benzinga","2025-03-11T00:31:00",{"slug":191,"title":192,"modified":193},"gurufocus","Gurufocus","2025-03-11T00:31:12",{"slug":195,"title":196,"modified":197},"fast-graphs","FAST Graphs","2025-03-11T00:31:19",{"slug":199,"title":200,"modified":201},"tipranks","TipRanks","2025-03-11T00:31:26",{"slug":203,"title":204,"modified":205},"seeking-alpha","Seeking Alpha","2025-03-11T00:31:45",{"slug":207,"title":208,"modified":209},"thestreet","TheStreet","2025-03-11T00:31:52",{"slug":211,"title":212,"modified":213},"investing-com","Investing.com","2025-03-11T00:32:00",{"slug":215,"title":216,"modified":217},"zacks","Zacks","2025-03-26T15:40:40",{"slug":219,"title":220,"modified":221},"alphasense","AlphaSense","2025-03-11T00:32:15",{"post":223,"seo":259,"relatedPosts":265,"suggestedPosts":341},{"id":224,"title":225,"date":226,"modified":227,"excerpt":228,"content":229,"wordCount":230,"lang":231,"uri":232,"slug":233,"cloudinaryAssetId":234,"featuredImageOriginalUrl":235,"featuredImageMetadata":236,"author":239,"editor":245,"categories":250,"relatedPosts":256,"seo":257},87702,"¿A quién pertenece Jazz Pharmaceuticals? Principales accionistas y últimas operaciones con información privilegiada","2026-01-02T22:23:40","2026-01-02T22:27:13","\u003Cp>A continuación se muestra quién tiene las mayores participaciones en Jazz Pharmaceuticals en la actualidad y qué sugieren los recientes cambios en la propiedad y la actividad de información privilegiada sobre la confianza en las perspectivas de beneficios a largo plazo de la empresa.\u003C\u002Fp>\n","\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=6724933&tid=34691179&ref=srk6m3\">\u003Cstrong>Jazz Pharmaceuticals (NASDAQ: JAZZ)\u003C\u002Fstrong>\u003C\u002Fa> es una empresa biofarmacéutica mundial centrada en terapias neurocientíficas y oncológicas. Las acciones cotizaron recientemente en torno a \u003Cstrong> los 173 dólares por título\u003C\u002Fstrong>, lo que supone una capitalización bursátil de unos \u003Cstrong> 10.300 millones de dólares\u003C\u002Fstrong>.\u003C\u002Fp>\n\n\n\n\u003Cp>Tras repuntar con fuerza el año pasado, Jazz Pharmaceuticals cotiza ahora muy por encima de sus mínimos anteriores, aun cuando las expectativas de crecimiento siguen siendo moderadas y el apalancamiento sigue formando parte de la narrativa de inversión. \u003C\u002Fp>\n\n\n\n\u003Cp>El análisis de quiénes son los propietarios de Jazz Pharmaceuticals y de cómo han operado los conocedores de la compañía ayuda a mostrar cómo las grandes instituciones y los directivos de la empresa pueden estar enfocando las acciones en la actualidad.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">Descubra el potencial de revalorización de sus valores favoritos con el nuevo modelo de valoración de TIKR (gratuito) >>>.\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-who-are-jazz-pharmaceuticals-top-shareholders\">\u003Cstrong>\u003Cstrong>¿Quiénes son los principales accionistas de Jazz Pharmaceuticals?\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"1481\" height=\"813\" data-public-id=\"images\u002FJAZZ-2_877102e380\u002FJAZZ-2_877102e380.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1481,h_813,c_scale\u002Ff_webp,q_auto\u002Fv1767392354\u002Fimages\u002FJAZZ-2_877102e380\u002FJAZZ-2_877102e380.webp?_i=AA\" alt=\"Jazz Pharmaceuticals stock\" class=\"wp-post-87702 wp-image-87710\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1767392354\" data-seo=\"1\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Principales accionistas de Jazz Pharmaceuticals\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>La base accionarial de Jazz Pharmaceuticals está encabezada por grandes inversores institucionales, en particular gestores de activos pasivos y a largo plazo. Estas empresas tienden a mantenerse a lo largo de los ciclos del mercado, lo que puede contribuir a la estabilidad de la propiedad, mientras que los cambios entre los gestores activos pueden reflejar cambios de opinión sobre la valoración o el rendimiento a corto plazo.\u003C\u002Fp>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Grupo Vanguard\u003C\u002Fstrong>: 5.882.899 acciones (9,68%), valor ~1.0B$. Redujo sus participaciones en 184.810 acciones (-3,05%).\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>BlackRock Institutional Trust Company\u003C\u002Fstrong>: 5.013.843 acciones (8,25%), valor de ~852,4 millones de dólares. Ha reducido su participación en 208.461 acciones (-3,99%).\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Dimensional Fund Advisors\u003C\u002Fstrong>: 2.836.652 acciones (4,67%), valor de ~482,2 millones de dólares. Añadidas 298.815 acciones (+11,77%).\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Capital World Investors\u003C\u002Fstrong>: 2.554.867 acciones (4,20%), valor de ~434,3 millones de dólares. Añadidas 10.345 acciones (+0,41%).\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>LSV Asset Management\u003C\u002Fstrong>: 2.511.858 acciones (4,13%), por un valor de ~427,0 millones de dólares. Ha reducido su participación en 41.884 acciones (-1,64%).\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>State Street Investment Management (US)\u003C\u002Fstrong>: 1.867.886 acciones (3,07%), valor de ~317,5 millones de dólares. Ha reducido su participación en 67.499 acciones (-3,49%).\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>EcoR1 Capital\u003C\u002Fstrong>: 1.706.469 acciones (2,81%), por un valor de ~290,1 millones de dólares. Sin cambios trimestrales.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>JPMorgan Asset\u003C\u002Fstrong> Management: 1.701.555 acciones (2,80%), valor de ~289,3 millones de dólares. Añadidas 152.322 acciones (+9,83%).\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Fuller & Thaler Asset Management\u003C\u002Fstrong>: 1.626.136 acciones (2,68%), valor ~$276,4M. Ha reducido su participación en 2.823 acciones (-0,17%).\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Columbia Threadneedle Investments (EE.UU.)\u003C\u002Fstrong>: 1.568.989 acciones (2,58%), valor de ~266,7 millones de dólares. Añadidas 29.168 acciones (+1,89%).\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>La propiedad sigue concentrada entre los titulares institucionales a largo plazo, con recortes por parte de algunos grandes gestores pasivos equilibrados por compras selectivas de empresas activas, lo que para los inversores sugiere un apoyo básico constante junto con opiniones dispares sobre las subidas a corto plazo.\u003C\u002Fp>\n\n\n\n\u003Ch3 class=\"wp-block-heading\" id=\"h-hedge-fund-highlights\">Hechos destacados de los hedge funds\u003C\u002Fh3>\n\n\n\n\u003Cp>Balyasny Asset Management LP, fundada por Dmitry Balyasny, aumentó su participación en Jazz Pharmaceuticals un \u003Cstrong>29,19%\u003C\u002Fstrong> el trimestre pasado y ahora posee aproximadamente \u003Cstrong> 57,09 millones de dólares\u003C\u002Fstrong> en acciones. El aumento sugiere un compromiso creciente tras la reciente recuperación de la acción.\u003C\u002Fp>\n\n\n\n\u003Cp>Schonfeld Strategic Advisors, fundada por Steven Schonfeld, amplió fuertemente su posición en Jazz, aumentando su participación en un \u003Cstrong>592,11%\u003C\u002Fstrong>, hasta un valor aproximado de \u003Cstrong> 57,52 millones de dólares\u003C\u002Fstrong>. El movimiento destaca entre los fondos multiestrategia que añadieron exposición durante el periodo.\u003C\u002Fp>\n\n\n\n\u003Cp>D. E. Shaw & Co., fundada por David E. Shaw, aumentó su exposición a Jazz en un \u003Cstrong>3.083,97%\u003C\u002Fstrong>, elevando su posición a un \u003Cstrong> valor\u003C\u002Fstrong> aproximado de \u003Cstrong> 16,39 millones de dólares\u003C\u002Fstrong>. Aunque sigue siendo una asignación pequeña en relación con el tamaño de la empresa, la magnitud del aumento es notable.\u003C\u002Fp>\n\n\n\n\u003Cp>Citadel Advisors, fundada por Ken Griffin, aumentó su participación en Jazz en un \u003Cstrong>42,07%\u003C\u002Fstrong> y ahora posee aproximadamente \u003Cstrong> 116,50 millones de dólares\u003C\u002Fstrong> en acciones. La posición sigue siendo una parte modesta de la cartera de Citadel, lo que para los inversores apunta a un amplio interés de los fondos de cobertura más que a una única apuesta concentrada.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Siga a los principales accionistas de más de 50.000 valores mundiales (es gratis) >>>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-jazz-pharmaceuticals-recent-insider-trades\">\u003Cstrong>\u003Cstrong>Últimas operaciones con información privilegiada de Jazz Pharmaceuticals\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"1481\" height=\"797\" data-public-id=\"images\u002FJAZZ-3\u002FJAZZ-3.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1481,h_797,c_scale\u002Ff_webp,q_auto\u002Fv1767392353\u002Fimages\u002FJAZZ-3\u002FJAZZ-3.webp?_i=AA\" alt=\"Jazz Pharmaceuticals stock\" class=\"wp-post-87702 wp-image-87711\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1767392353\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1767392353\u002Fimages\u002FJAZZ-3\u002FJAZZ-3.webp?_i=AA 1481w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_161,c_scale\u002Ff_webp,q_auto\u002Fv1767392353\u002Fimages\u002FJAZZ-3\u002FJAZZ-3.webp?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_551,c_scale\u002Ff_webp,q_auto\u002Fv1767392353\u002Fimages\u002FJAZZ-3\u002FJAZZ-3.webp?_i=AA 1024w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_413,c_scale\u002Ff_webp,q_auto\u002Fv1767392353\u002Fimages\u002FJAZZ-3\u002FJAZZ-3.webp?_i=AA 768w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1200,h_646,c_scale\u002Ff_webp,q_auto\u002Fv1767392353\u002Fimages\u002FJAZZ-3\u002FJAZZ-3.webp?_i=AA 1200w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_753,c_scale\u002Ff_webp,q_auto\u002Fv1767392353\u002Fimages\u002FJAZZ-3\u002FJAZZ-3.webp?_i=AA 1400w\" sizes=\"auto, (max-width: 1481px) 100vw, 1481px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Últimas operaciones con información privilegiada de Jazz Pharmaceuticals\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>Las operaciones con información privilegiada pueden ofrecer un contexto sobre cómo los ejecutivos y directores pueden estar gestionando la exposición personal a las acciones. Los archivos recientes de Jazz Pharmaceuticals muestran múltiples transacciones, principalmente agrupadas en torno a mediados de noviembre.\u003C\u002Fp>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Bruce C. Cozadd (Director)\u003C\u002Fstrong>: Vendió aproximadamente \u003Cstrong>17.000 acciones\u003C\u002Fstrong> en múltiples transacciones entre \u003Cstrong> 180,09 y 182,60 dólares\u003C\u002Fstrong>; también registró \u003Cstrong>2.506 acciones a 0 dólares\u003C\u002Fstrong>.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Heather Ann McSharry (Directora)\u003C\u002Fstrong>: Vendió \u003Cstrong>3.415 acciones a 177,78 dólares\u003C\u002Fstrong>; adquirió \u003Cstrong>3.415 acciones a 138,08 dólares\u003C\u002Fstrong>.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Mary Elizabeth Henderson (Directora)\u003C\u002Fstrong>: Vendió \u003Cstrong>1.331 acciones a 180,40 dólares\u003C\u002Fstrong>.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Rick E. Winningham (Director)\u003C\u002Fstrong>: Vendió \u003Cstrong>5.500 acciones a 180,86 dólares\u003C\u002Fstrong>.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Patricia Carr (Funcionaria)\u003C\u002Fstrong>: Vendió \u003Cstrong>5.250 acciones a 182,\u003C\u002Fstrong>07 $; adquirió \u003Cstrong>5.250 acciones a 136,18 $\u003C\u002Fstrong>; vendió \u003Cstrong>69 acciones a 181,66 $\u003C\u002Fstrong>.\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>Parece que la actividad con información privilegiada se inclina hacia la venta a precios cercanos a los máximos recientes, con algunas adquisiciones compensatorias a niveles más bajos, lo que para los inversores proporciona contexto pero no altera materialmente la propiedad global.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Ver datos recientes de operaciones con información privilegiada de más de 50.000 valores mundiales (es gratis) >>>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-the-ownership-amp-insider-trade-data-tell-us\">Qué nos dicen los datos sobre propiedad y operaciones con información privilegiada\u003C\u002Fh2>\n\n\n\n\u003Cp>La base accionarial de Jazz Pharmaceuticals sigue anclada en los grandes inversores institucionales, incluso cuando algunos gestores pasivos recortaron posiciones. La actividad de los hedge funds se ha inclinado hacia una mayor exposición, mientras que las operaciones con información privilegiada parecen moderadas tras el repunte de la acción.\u003C\u002Fp>\n\n\n\n\u003Cp>Para los inversores, esta combinación sugiere un sentimiento equilibrado, con el apoyo institucional intacto pero un posicionamiento que refleja cautela mientras la empresa navega entre expectativas de crecimiento moderadas, consideraciones de apalancamiento y un precio de la acción que ya se ha movido significativamente al alza.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-value-any-stock-in-under-60-seconds-it-s-free\">\u003Cstrong>\u003Cstrong>\u003Cstrong>Valore cualquier acción en menos de 60 segundos (es gratis)\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Con la \u003Cstrong>nueva herramienta Modelo de valoración\u003C\u002Fstrong> de TIKR, puede estimar el precio potencial de una acción en menos de un minuto.\u003C\u002Fp>\n\n\n\n\u003Cp>Todo lo que necesita son tres simples datos:\u003C\u002Fp>\n\n\n\n\u003Col class=\"wp-block-list\">\n\u003Cli>\u003Cem>Crecimiento de los ingresos\u003C\u002Fem>\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cem>Márgenes operativos\u003C\u002Fem>\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cem>Múltiplo PER de salida\u003C\u002Fem>\u003C\u002Fli>\n\u003C\u002Fol>\n\n\n\n\u003Cp>A partir de ahí, TIKR calcula el precio potencial de la acción y la rentabilidad total en los \u003Cstrong>escenarios\u003C\u002Fstrong> \u003Cstrong>alcista, bajista y básico\u003C\u002Fstrong>, para que pueda ver rápidamente si una acción parece \u003Cstrong>infravalorada o sobrevalorada\u003C\u002Fstrong>.\u003C\u002Fp>\n\n\n\n\u003Cp>Si no está seguro de qué introducir, TIKR rellena automáticamente cada entrada utilizando las estimaciones de consenso de los analistas, ofreciéndole un punto de partida rápido y fiable.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">Vea el valor real de una acción en menos de 60 segundos (gratis con TIKR) >>>\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n",868,"es","\u002Fblog\u002Fwho-owns-jazz-pharmaceuticals-top-shareholders-and-recent-insider-trades","who-owns-jazz-pharmaceuticals-top-shareholders-and-recent-insider-trades","images\u002FJazz-Pharmaceuticals-stock-1\u002FJazz-Pharmaceuticals-stock-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767392737\u002Fimages\u002FJazz-Pharmaceuticals-stock-1\u002FJazz-Pharmaceuticals-stock-1.png?_i=AA",{"altText":237,"imageCredit":238},"Who Owns Jazz Pharmaceuticals? Top Shareholders and Recent Insider Trades","@baehakqinugroho from baehakqinugroho's Images via Canva",{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":244},"Nikko Henson","nikkotikr","author","",[],{"name":246,"slug":247,"role":248,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":249},"Thomas Richmond","thomastikr","editor",[],[251],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},"Reseñas de Acciones","reviews","\u002Fblog\u002Fcategory\u002Freviews",0,[],{"title":237,"metaDesc":258,"opengraphDescription":258,"twitterTitle":237,"twitterDescription":258},"Here’s who holds the biggest stakes in Jazz Pharmaceuticals today and what recent shifts in ownership and insider activity suggest about confidence in the company’s long term earnings outlook.",{"title":237,"description":258,"twitterTitle":237,"twitterDescription":258,"author":240,"articlePublisher":260,"articlePublishedTime":226,"articleModifiedTime":227,"twitterLabel1":261,"twitterData1":262,"ogTitle":237,"ogDescription":258,"ogUrl":232,"ogImage":235,"ogImageWidth":263,"ogImageHeight":264,"ogImageSecureUrl":235,"ogImageAlt":237,"twitterImage":235},"TIKR.com","Tiempo de lectura estimado","6 minutes",1200,630,[266,281,296,311,326],{"id":255,"title":267,"date":268,"excerpt":269,"wordCount":270,"uri":271,"slug":272,"cloudinaryAssetId":273,"featuredImageOriginalUrl":274,"featuredImageMetadata":275,"author":276,"categories":278,"relatedPosts":280},"¿A quién pertenece IQVIA Holdings? Principales accionistas y últimas operaciones con información privilegiada","2026-01-02 21:45:26","A continuación, se explica quién posee las mayores participaciones en IQVIA Holdings en la actualidad y qué sugieren los recientes cambios en la propiedad sobre la confianza en las perspectivas de crecimiento a largo plazo de la compañía.",925,"\u002Fblog\u002Fwho-owns-iqvia-holdings-top-shareholders-and-recent-insider-trades","who-owns-iqvia-holdings-top-shareholders-and-recent-insider-trades","images\u002FIQVIA-Holdings-stock\u002FIQVIA-Holdings-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767390039\u002Fimages\u002FIQVIA-Holdings-stock\u002FIQVIA-Holdings-stock.png?_i=AA",{"altText":267},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":277},[],[279],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":282,"date":283,"excerpt":284,"wordCount":285,"uri":286,"slug":287,"cloudinaryAssetId":288,"featuredImageOriginalUrl":289,"featuredImageMetadata":290,"author":291,"categories":293,"relatedPosts":295},"¿A quién pertenece Incyte Corporation? Principales accionistas y últimas operaciones con información privilegiada","2026-01-02 19:38:12","A continuación se muestra quién tiene las mayores participaciones en Incyte Corporation en la actualidad y qué sugieren los recientes cambios en la propiedad y la actividad de información privilegiada sobre la confianza en las perspectivas de beneficios y proyectos a largo plazo de la empresa.",893,"\u002Fblog\u002Fwho-owns-incyte-corporation-top-shareholders-and-recent-insider-trades","who-owns-incyte-corporation-top-shareholders-and-recent-insider-trades","images\u002FIncyte-stock\u002FIncyte-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767382563\u002Fimages\u002FIncyte-stock\u002FIncyte-stock.png?_i=AA",{"altText":282},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":292},[],[294],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":297,"date":298,"excerpt":299,"wordCount":300,"uri":301,"slug":302,"cloudinaryAssetId":303,"featuredImageOriginalUrl":304,"featuredImageMetadata":305,"author":306,"categories":308,"relatedPosts":310},"¿A quién pertenece Illumina? Principales accionistas y últimas operaciones con información privilegiada","2026-01-02 19:16:04","A continuación se indica quiénes poseen las mayores participaciones en Illumina en la actualidad y qué sugieren las recientes actividades de propiedad y de información privilegiada sobre la confianza en sus perspectivas de crecimiento a largo plazo.",875,"\u002Fblog\u002Fwho-owns-illumina-top-shareholders-and-recent-insider-trades","who-owns-illumina-top-shareholders-and-recent-insider-trades","images\u002FIllumina-stock_8770072baa\u002FIllumina-stock_8770072baa","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767381316\u002Fimages\u002FIllumina-stock_8770072baa\u002FIllumina-stock_8770072baa.png?_i=AA",{"altText":297},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":307},[],[309],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":312,"date":313,"excerpt":314,"wordCount":315,"uri":316,"slug":317,"cloudinaryAssetId":318,"featuredImageOriginalUrl":319,"featuredImageMetadata":320,"author":321,"categories":323,"relatedPosts":325},"¿A quién pertenece Hologic? Principales accionistas y últimas operaciones con información privilegiada","2026-01-02 18:53:27","A continuación se muestra quién tiene las mayores participaciones en Hologic en la actualidad y qué sugieren los recientes cambios en la propiedad y la actividad de información privilegiada sobre la confianza en la estabilidad de los beneficios a largo plazo de la empresa y la demanda de salud de la mujer.",912,"\u002Fblog\u002Fwho-owns-hologic-top-shareholders-and-recent-insider-trades","who-owns-hologic-top-shareholders-and-recent-insider-trades","images\u002FHologic-stock\u002FHologic-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767379949\u002Fimages\u002FHologic-stock\u002FHologic-stock.png?_i=AA",{"altText":312},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":322},[],[324],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":327,"date":328,"excerpt":329,"wordCount":330,"uri":331,"slug":332,"cloudinaryAssetId":333,"featuredImageOriginalUrl":334,"featuredImageMetadata":335,"author":336,"categories":338,"relatedPosts":340},"¿A quién pertenece Edwards Lifesciences? Principales accionistas y últimas operaciones con información privilegiada","2026-01-02 17:44:32","A continuación se muestra quién tiene las mayores participaciones en Edwards Lifesciences en la actualidad y qué sugieren la reciente propiedad y la actividad de información privilegiada sobre el crecimiento a largo plazo y la demanda cardiaca estructural.",845,"\u002Fblog\u002Fwho-owns-edwards-lifesciences-top-shareholders-and-recent-insider-trades","who-owns-edwards-lifesciences-top-shareholders-and-recent-insider-trades","images\u002FEdwards-Lifesciences-stock_87692d9b10\u002FEdwards-Lifesciences-stock_87692d9b10","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767375348\u002Fimages\u002FEdwards-Lifesciences-stock_87692d9b10\u002FEdwards-Lifesciences-stock_87692d9b10.png?_i=AA",{"altText":327},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":337},[],[339],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],[342,361,376,391,406,421,441,456,471,488],{"id":255,"title":343,"date":344,"excerpt":345,"wordCount":346,"uri":347,"slug":348,"cloudinaryAssetId":-1,"featuredImageOriginalUrl":349,"featuredImageMetadata":350,"author":351,"categories":355,"relatedPosts":360},"Por qué las acciones de Broadcom (AVGO) subieron un 50% en 2025","2026-01-02 14:45:00","Broadcom (AVGO), que ha caído un 15% desde sus máximos históricos, es un valor tecnológico de gran capitalización que ha devuelto un 50% a sus accionistas en 2025. ",656,"\u002Fblog\u002Fwhy-broadcom-nasdaq-avgo-stock-rose-50-in-2025","why-broadcom-nasdaq-avgo-stock-rose-50-in-2025","https:\u002F\u002Ftikr1.wpengine.com\u002Fwp-content\u002Fuploads\u002F2026\u002F01\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-8-600x400.png",{"altText":343},{"name":352,"slug":353,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":354},"Aditya Raghunath","adityatikr",[],[356],{"name":357,"slug":358,"uri":359,"description":243,"postsCount":255},"Inversión General","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",[],{"id":255,"title":362,"date":363,"excerpt":364,"wordCount":365,"uri":366,"slug":367,"cloudinaryAssetId":368,"featuredImageOriginalUrl":369,"featuredImageMetadata":370,"author":371,"categories":373,"relatedPosts":375},"Por qué las acciones de Kratos Defense subieron un 190% en 2025","2026-01-02 14:15:00","Las acciones de Kratos Defense casi triplicaron el patrimonio de los inversores el año pasado, ya que la empresa de seguridad sigue ampliando su foso competitivo. ",1160,"\u002Fblog\u002Fwhy-kratos-defense-nasdaq-ktos-stock-surged-190-in-2025","why-kratos-defense-nasdaq-ktos-stock-surged-190-in-2025","images\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-7\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-7","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767361825\u002Fimages\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-7\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-7.png?_i=AA",{"altText":362},{"name":352,"slug":353,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":372},[],[374],{"name":357,"slug":358,"uri":359,"description":243,"postsCount":255},[],{"id":255,"title":377,"date":378,"excerpt":379,"wordCount":380,"uri":381,"slug":382,"cloudinaryAssetId":383,"featuredImageOriginalUrl":384,"featuredImageMetadata":385,"author":386,"categories":388,"relatedPosts":390},"Por qué las acciones de Dollar Tree subieron un 64% en 2025","2026-01-02 13:45:00","Las acciones de Dollar Tree subieron un 64% en 2025, aplastando los rendimientos del mercado en general, ya que el minorista de descuento se centró en sus esfuerzos de reconversión. ",966,"\u002Fblog\u002Fwhy-dollar-tree-nasdaq-dltr-stock-rose-64-in-2025","why-dollar-tree-nasdaq-dltr-stock-rose-64-in-2025","images\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-5_8767165956\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-5_8767165956","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767360245\u002Fimages\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-5_8767165956\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-5_8767165956.png?_i=AA",{"altText":377},{"name":352,"slug":353,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":387},[],[389],{"name":357,"slug":358,"uri":359,"description":243,"postsCount":255},[],{"id":255,"title":392,"date":393,"excerpt":394,"wordCount":395,"uri":396,"slug":397,"cloudinaryAssetId":398,"featuredImageOriginalUrl":399,"featuredImageMetadata":400,"author":401,"categories":403,"relatedPosts":405},"Por qué las acciones de Nebius subieron un 200% en 2025","2026-01-02 12:00:00","Las acciones de Nebius, que han caído un 40% desde sus máximos históricos, se han triplicado con creces en 2025 a medida que ganan terreno en el mercado de la IA, en rápida expansión. ",888,"\u002Fblog\u002Fwhy-nebius-nasdaq-nbis-stock-rose-200-in-2025","why-nebius-nasdaq-nbis-stock-rose-200-in-2025","images\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-3_87666ecc87\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-3_87666ecc87","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767353835\u002Fimages\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-3_87666ecc87\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-3_87666ecc87.png?_i=AA",{"altText":392},{"name":352,"slug":353,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":402},[],[404],{"name":357,"slug":358,"uri":359,"description":243,"postsCount":255},[],{"id":255,"title":407,"date":408,"excerpt":409,"wordCount":410,"uri":411,"slug":412,"cloudinaryAssetId":413,"featuredImageOriginalUrl":414,"featuredImageMetadata":415,"author":416,"categories":418,"relatedPosts":420},"Por qué las acciones de Asana cayeron un 32% en 2025","2026-01-02 11:15:00","Con una caída de más del 90% desde sus máximos históricos, las acciones de Asana siguieron registrando un rendimiento inferior al de los mercados más amplios en 2025. ",731,"\u002Fblog\u002Fwhy-asana-stock-fell-32-in-2025","why-asana-stock-fell-32-in-2025","images\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15_876606fa98\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15_876606fa98","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767351571\u002Fimages\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15_876606fa98\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15_876606fa98.png?_i=AA",{"altText":407},{"name":352,"slug":353,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":417},[],[419],{"name":357,"slug":358,"uri":359,"description":243,"postsCount":255},[],{"id":255,"title":422,"date":423,"excerpt":424,"wordCount":425,"uri":426,"slug":427,"cloudinaryAssetId":428,"featuredImageOriginalUrl":429,"featuredImageMetadata":430,"author":431,"categories":435,"relatedPosts":440},"CaixaBank acaba de alcanzar máximos históricos. Podrá seguir subiendo en 2026?","2025-12-31 15:15:00","A pesar de un repunte masivo, nuestro modelo muestra que las acciones de CABK podrían rendir alrededor de un 15% hasta 2030 a medida que su negocio de seguros se dispare.",987,"\u002Fblog\u002Fcaixabank-just-hit-all-time-highs-can-the-stock-keep-climbing-in-2026","caixabank-just-hit-all-time-highs-can-the-stock-keep-climbing-in-2026","images\u002F2_873969caee\u002F2_873969caee","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767053079\u002Fimages\u002F2_873969caee\u002F2_873969caee.png?_i=AA",{"altText":422},{"name":432,"slug":433,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":434},"Wiltone Asuncion","wiltonetikr",[],[436],{"name":437,"slug":438,"uri":439,"description":243,"postsCount":255},"Valoración","valuation","\u002Fblog\u002Fcategory\u002Fvaluation",[],{"id":255,"title":442,"date":443,"excerpt":444,"wordCount":445,"uri":446,"slug":447,"cloudinaryAssetId":448,"featuredImageOriginalUrl":449,"featuredImageMetadata":450,"author":451,"categories":453,"relatedPosts":455},"Las acciones del Banco Bilbao Vizcaya Argentaria (BBVA) han subido un 110% este año, ¿todavía tienen recorrido?","2025-12-31 14:30:00","A pesar de unos márgenes operativos de primera clase, nuestro modelo prevé una rentabilidad anualizada del -1,2% para las acciones de BBVA en los próximos dos años.",1095,"\u002Fblog\u002Fup-110-this-year-does-banco-bilbao-vizcaya-argentaria-bbva-stock-still-have-room-to-run","up-110-this-year-does-banco-bilbao-vizcaya-argentaria-bbva-stock-still-have-room-to-run","images\u002FCopy-of-Random-Featured-Image-1-1\u002FCopy-of-Random-Featured-Image-1-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1766137070\u002Fimages\u002FCopy-of-Random-Featured-Image-1-1\u002FCopy-of-Random-Featured-Image-1-1.png?_i=AA",{"altText":442},{"name":432,"slug":433,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":452},[],[454],{"name":437,"slug":438,"uri":439,"description":243,"postsCount":255},[],{"id":255,"title":457,"date":458,"excerpt":459,"wordCount":460,"uri":461,"slug":462,"cloudinaryAssetId":463,"featuredImageOriginalUrl":464,"featuredImageMetadata":465,"author":466,"categories":468,"relatedPosts":470},"Las acciones del Banco de Sabadell han subido un 300% en los últimos 3 años, ¿podrán continuar su racha en 2026?","2025-12-30 16:15:00","Esta es la razón por la que las acciones de Banco Sabadell han subido un 87% desde sus mínimos de 52 semanas. Las acciones de Banco Sabadell podrían alcanzar su precio objetivo de 3,58 euros en 2029. ",1088,"\u002Fblog\u002Fup-300-over-the-past-3-years-can-banco-de-sabadell-stock-continue-its-run-in-2026","up-300-over-the-past-3-years-can-banco-de-sabadell-stock-continue-its-run-in-2026","images\u002FCopy-of-Random-Featured-Image-2\u002FCopy-of-Random-Featured-Image-2","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1766141023\u002Fimages\u002FCopy-of-Random-Featured-Image-2\u002FCopy-of-Random-Featured-Image-2.png?_i=AA",{"altText":457},{"name":432,"slug":433,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":467},[],[469],{"name":437,"slug":438,"uri":439,"description":243,"postsCount":255},[],{"id":255,"title":472,"date":473,"excerpt":474,"wordCount":475,"uri":476,"slug":477,"cloudinaryAssetId":478,"featuredImageOriginalUrl":479,"featuredImageMetadata":480,"author":481,"categories":485,"relatedPosts":487},"Por qué Netflix podría superar los 131 dólares por acción y alcanzar máximos históricos en 2026","2025-12-30 15:45:00","Netflix podría ofrecer una rentabilidad superior al 30% en 2027, ya que el crecimiento constante de los ingresos, la expansión de los márgenes y unas hipótesis de valoración estables respaldan el alza impulsada por los beneficios.",1212,"\u002Fblog\u002Fheres-why-netflix-could-pass-131-share-and-potentially-reach-all-time-highs-in-2026","heres-why-netflix-could-pass-131-share-and-potentially-reach-all-time-highs-in-2026","images\u002FFEATURED-IMAGE-MAKER-3_86684d6804\u002FFEATURED-IMAGE-MAKER-3_86684d6804","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1765994506\u002Fimages\u002FFEATURED-IMAGE-MAKER-3_86684d6804\u002FFEATURED-IMAGE-MAKER-3_86684d6804.png?_i=AA",{"altText":472},{"name":482,"slug":483,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":484},"Gian Estrada","giantikr",[],[486],{"name":437,"slug":438,"uri":439,"description":243,"postsCount":255},[],{"id":255,"title":489,"date":490,"excerpt":491,"wordCount":492,"uri":493,"slug":494,"cloudinaryAssetId":495,"featuredImageOriginalUrl":496,"featuredImageMetadata":497,"author":498,"categories":500,"relatedPosts":502},"Por qué este valor de mediana capitalización podría subir un 100% en los próximos dos años","2025-12-30 12:30:00","dLocal es un valor de crecimiento de mediana capitalización que cotiza con una valoración atractiva dadas sus estimaciones estelares de ingresos y beneficios. ",1121,"\u002Fblog\u002Fwhy-this-mid-cap-nasdaq-dlo-stock-could-surge-100-over-the-next-two-years","why-this-mid-cap-nasdaq-dlo-stock-could-surge-100-over-the-next-two-years","images\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-1\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767093096\u002Fimages\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-1\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-1.png?_i=AA",{"altText":489},{"name":352,"slug":353,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":499},[],[501],{"name":437,"slug":438,"uri":439,"description":243,"postsCount":255},[]]